Inga kliniskt signifikanta skillnader observerades med avseende på QT, PR, QRS eller QTcB mellan duloxetinbehandlade och placebobehandlade patienter. ###>No clinically significant differences were observed for QT, PR, QRS, or QTcB measurements between duloxetine-treated and placebo-treated patients.